270 Life Sciences Private Capital

VC firm · New York, NY

Verified active in the last 12 months

Venture firm based in New York, NY. 1 deal vehicle (SPVs) filed with the SEC since Sep 2026. Partners sit on the boards of 3 startups that raised recently.

Stages: Growth
Typical check (est.): Not disclosed
Latest fund: Undisclosed · Sep 2026
Last verified activity: Sep 2026

Focus

Biotech & PharmaHealthcare

Recent portfolio activity

Cayman
SPV
Sep 2026
Raintank
Board seat · NY
Mar 2026
Enlaza Therapeutics
Board seat · CA
Aug 2024
Averna Therapeutics
Board seat · MA
Apr 2024

Funds and vehicles on SEC file

270 Life Sciences Private Capital Fund II (US) LP
Fund
Sep 2026
270 Life Sciences Private Capital Fund II (Cayman) LP
Deal vehicle
Sep 2026

Sources

SEC Form D: 270 Life Sciences Private Capital Fund II (US) LPSep 16, 2026
SEC Form D: 270 Life Sciences Private Capital Fund II (Cayman) LPSep 16, 2026

Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.